Key Takeaways
- Fire reshapes FY26, but the battery thesis is intact: The Dahej fire forced a FY26 revenue guidance cut to ₹775–₹850 crore, yet the battery chemicals build-out is accelerating with a Morita JV, salt commissioning, and electrolyte trials all progressing.
- Battery revenue target narrowed to ~₹300 crore for FY26: Earlier ₹300–₹500 crore range tightened to the lower end, with most revenue back-loaded into H2 and dependent on customer approvals.
- Morita JV is a strategic unlock, not just a technology deal: The 100-year-old Japanese partner brings 30 years of LiPF6 expertise, best-in-class quality, and a customer-approval track record with all major non-China electrolyte makers, plus strategic capital.
- Margins held up despite the shock: FY25 EBITDA grew 24% to ₹136 crore with margins at 17.5%, driven by volume-led operating leverage and cost optimization, even with a 25-day plant outage.
- What to watch next quarter: Customer field audit outcomes in Q3, the pace of salt capacity commissioning (1,100 tonnes by September), and any further clarity on the Morita JV ownership and CAPEX split.
The Dahej Fire: Damage, Recovery & Financial Impact
- What burned: The March 5 fire hit the main manufacturing plant MPP-3, warehouse, and tank farms at Dahej. No injuries or casualties. Production was suspended and shifted to other sites subject to customer approvals.
- Insurance coverage: Both asset damage and business interruption are fully covered on a reinstatement basis, so replacement CAPEX will be funded by insurance outflows. Banks have offered temporary bridge loans if needed.
- Replacement timeline: Construction of a replacement plant at an adjacent location within the same site has begun; management targets operational readiness by Q4 FY26.
- Asset write-off: Only damaged assets (MPP-3 and warehouse) were written off. The balance utility section, ETP section, admin building, and NIL block continued as is. The exact amount written off was not disclosed.
- Gross block reduction: Entirely attributable to the fire; no other reason.
- Q4 PAT hit: PAT stood lower at ₹2 crore primarily due to exceptional factors related to the fire incident.
- Neogen Ionics impact: Revenue would have been higher but for the fire, which caused loss of finished goods inventory and disrupted the majority of salt shipments planned for quarter-end.
- Margin protection: Management expects the margin trajectory to hold except for some impact from moving production or outsourcing, which should ideally be covered by the business interruption insurance (loss-on-profit policy), with recognition likely in Q4 or next year.
Dr. Harin Kanani: "While this incident has necessitated a revision of our FY26 revenue guidance of Rs. 775 crore to Rs. 850 crore, we are taking all necessary steps to restore normalcy and minimize disruption."
Battery Chemicals: The Build-Out Accelerates
Salt capacity & commissioning
- 200 tonnes per annum of lithium electrolyte salts capacity already commissioned; first approved material shipped to customers.
- 1,100 tonnes to be commissioned by September 2025, and another 1,000 tonnes by March 2026.
- Dahej salt capacity being fast-tracked to 2,500 tonnes at customer request; customers want shipments from Q3 FY26, with major ramp-up expected in Q4.
- Pakhajan salt site targeting Q4 for commissioning; revenue contribution starts next year.
Electrolyte progress
- 2,000 tonnes of electrolyte fully commissioned; a major ACC battery manufacturer has commenced trial production.
- Commercial production expected by Q1 or Q2 FY26; initial capacity aligned with the ACC manufacturer's requirement.
- Greenfield battery materials facility (MUIS technology): civil work and engineering nearing completion; modular plant nearly done; major equipment expected on site by Q2 FY26; commissioning on track for March 2026 or earlier.
Customer approvals
- Field audits for US market customers (battery manufacturers and OEMs, aligned) targeted for completion in Q3. Post-audit, large-scale battery manufacturing trials begin; additional trials may follow.
- Management declined to specify whether the end customer is the battery manufacturer or the OEM, stating all parties are aligned.
- Final approval expected by Q3; commercial shipments should start sometime in Q3.
Dr. Harin Kanani: "This project will fast track our entry into high growth lithium-ion battery material segment, crucial for India's EV and energy storage industries. By becoming a domestic manufacturer at scale, Neogen can capture substantial market share, reduce India's import dependence and leverage our first mover advantage with proven global technology."
The Morita JV: Rationale, Structure & Competitive Edge
- Who Morita is: A 100-year-old Japanese chemical company that has manufactured LiPF6 in China for 30 years, competing successfully against Chinese producers. Their solid LiPF6 technology is considered best-in-class even within China.
- Why it matters for approvals: Almost all non-China electrolyte makers (three Korean, two Japanese) have used Morita's LiPF6, which accelerates customer approvals for Neogen. Their quality systems, process systems, and safety systems for handling AHF at large scale are superior.
- JV structure: Neogen will hold significantly more than 50%. The existing 3,000-tonne Pakhajan salt capacity and future salt capacities will be transferred to this JV subsidiary. The exact ownership percentage will be shared later.
- Timeline of discussions: Discussions with Morita began 2.5–3 years ago, parallel to Mitsubishi discussions. A JV took longer than a technology license because it represents a bigger commitment; the decision was not made in the last 3–6 months.
- Capacity allocation: The 2,500 tonnes in Dahej is a mix of additive and electrolyte salt (including LiPF6) and intermediates. The 3,000 tonnes in Pakhajan is exclusively for electrolyte salt using Morita technology. The 30,000 tonnes electrolyte capacity in Pakhajan uses Mitsubishi technology. Additives (1%–3% of formulation) carry slightly higher pricing and have fewer producers than electrolyte salt (10%–15% of formulation).
- Total CAPEX unchanged: Overall Neogen Ionics CAPEX in the battery space remains ~₹1,500 crore; the breakdown between NIL and the JV will be provided at a later date.
- Pricing philosophy: Management wants to earn margins through technology, not by playing on price differentials across markets on raw materials. Salt business pricing mechanisms have been concluded to ensure 20% ROCE; electrolyte pricing discussions are ongoing but the concept of pass-through pricing is accepted by customers in principle.
Dr. Harin Kanani: "Almost all non-China customers, the three Koreans and the two Japanese electrolyte makers, whether they are doing business in US or not, they have used their LiPF6. So we basically can work together and also get some capital which is coming in a strategic form."
FY25 Performance: Volume Resilience Offsets Price & Fire Headwinds
- Revenue: ₹778 crore, up 13% YoY, driven by strong volumes in the core business including BuLi Chem, despite a soft pricing environment and the 25-day Dahej plant outage in March.
- Organic vs inorganic split: Organic revenue ₹666 crore (up 22%); inorganic revenue ₹112 crore. Lower bromine prices reduced organic revenue by ₹81 crore; lower lithium prices reduced inorganic revenue by ₹16 crore.
- EBITDA: ₹136 crore, up 24% YoY, with margin improving to 17.5%, driven by operating leverage from higher volumes and continued cost optimization.
- Volume growth: Both organic and inorganic chemical segments demonstrated steady volumes; the company pivoted towards product applications with favorable demand including Semiconductor, Flavor & Fragrance, Ag-Chem, Pharma, and Industrial CSM.
- BuLi capacity expansion: Following environmental clearance approval, BuLi chemical facilities at Patancheru, Hyderabad more than doubled from 120 to 300 metric tonnes active capacity through de-bottlenecking.
- Working capital improvement (ex-fire): Debtor and creditor cycles both improved after management became more mindful following the previous year's ramp-up and customer mix change. Long-term policy goal: manage debtors and creditors to balance each other, secure better credit terms, and improve inventory visibility with larger molecules.
Guidance, Targets & the Path to Scale
- FY26 revenue guidance: Revised to ₹775–₹850 crore due to the fire incident.
- FY26 battery chemicals revenue: Closer to ₹300 crore (revised from ₹300–₹500 crore), with most revenue in H2. Electrolyte depends on local manufacturers' readiness: one gigafactory getting streamlined, a second likely to start by year-end, at least one more before Q4 FY26.
- FY27 battery chemicals revenue: Internally targeting a four-digit number (₹1,000 crore plus); capacity will exist to support this, but actual revenue depends on electrolyte market share and salt volume ramp-up.
- FY27 legacy business: Target ~₹1,100 crore revenue at full utilization with 18.5% ± 1% EBITDA margin.
- Battery chemicals at full utilization (₹2,500–₹2,900 crore revenue): 20% ROCE target; EBITDA margins of 16%–18% at normal lithium prices.
- Working capital targets: Standalone at 140–150 days at full utilization in FY26, with a long-term target of 110–120 days. Neogen Ionics: below 90 days. Consolidated: below 100 days over the next 2–3 years.
- All lithium CAPEX (~₹1,500 crore): Expected to be completed and capitalized by March 2026. Plant replacement CAPEX (~₹200–₹225 crore) also to be capitalized.
- Competitive positioning on salt pricing: Management acknowledged international salt prices are very low and believes they are unsustainable, but asserted Neogen remains one of the cheapest sources outside China.
Dr. Harin Kanani: "If you look internationally, yes, today the salt prices are very low. And we believe these are not sustainable. But the premise there was, are we the cheapest source outside China? And that still remains true that outside China, we remain one of the key cheapest sources."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY26 consolidated revenue | ₹775–₹850 crore | FY26 |
| FY26 battery chemicals revenue | Closer to ₹300 crore | FY26 |
| Replacement plant operational | Construction at adjacent Dahej location | Q4 FY26 |
| Salt capacity addition | 1,100 tonnes commissioned | September 2025 |
| Salt capacity addition | 1,000 tonnes commissioned | March 2026 |
| Electrolyte commercial production | Begin shipments | Q1 or Q2 FY26 |
| Greenfield battery materials facility | Commissioned (MUIS technology) | March 2026 or earlier |
| Customer field audits | Completed for US market customers | Q3 (implied FY26) |
| Commercial salt shipments | Start from Dahej fast-tracked capacity | Q3 FY26 |
| All lithium CAPEX | ~₹1,500 crore completed and capitalized | March 2026 |
| Standalone working capital cycle | 140–150 days at full utilization | FY26 |
| Consolidated working capital cycle | Below 100 days | Next 2–3 years |
| Legacy business EBITDA margin | 18.5% ± 1% at full utilization | FY27 |
| Battery chemicals ROCE at full utilization | 20% | At full utilization (₹2,500–₹2,900 crore revenue) |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Revenue | ₹203 cr |
| EBITDA | ₹36 cr |
| PAT | ₹2 cr, lower due to exceptional factors related to fire incident |
| FY25 revenue | ₹778 cr, +13% YoY |
| FY25 EBITDA | ₹136 cr, +24% YoY |
| FY25 EBITDA margin | 17.5%, increase YoY |
| FY25 organic revenue | ₹666 cr, +22% YoY |
| FY25 inorganic revenue | ₹112 cr |
| FY25 revenue breakdown: Bromine Derivatives | 44% of revenue |
| FY25 revenue breakdown: Advanced Intermediates and Contract | 31% of revenue |
| FY25 revenue breakdown: Organolithium (BuLi) | 11% of revenue |
| FY25 revenue breakdown: Inorganic Lithium Compounds | 11% of revenue |
| FY25 revenue breakdown: Battery | 1% of revenue |
| FY26 revenue guidance (revised due to fire) | ₹775–850 cr |
| FY26 Battery Chemicals revenue target | Closer to ₹300 cr, from earlier ₹300–500 cr range |
| FY27 legacy business revenue target | ~₹1,100 cr at full utilization |
| FY27 legacy business EBITDA margin target | 18.5% +/- 1% at full utilization |
| Battery Chemicals full utilization revenue projection | ₹2,500–2,900 cr at normal lithium price |
| Battery Chemicals full utilization EBITDA margin range | 16%–18% |
| Battery Chemicals ROCE target | 20% |
| Neogen Ionics FY25 revenue | ₹12 cr; would have been ₹5–8 cr higher absent fire |
| Total CAPEX incurred in Neogen Ionics for FY25 | ₹470 cr |
| Total Neogen Ionics battery CAPEX plan | ₹1,500 cr |
| Fire incident total loss | ~₹360 cr; ~₹160–180 cr inventory, balance physical assets |
| Fire loss replacement CAPEX | ~₹200–225 cr |
| BuLi capacity at Patancheru post de-bottlenecking | 300 metric tonnes active, up from 120 |
| Lithium electrolyte salts capacity commissioned | 200 metric tonnes per annum; trial ongoing for another 200 |
| Lithium electrolyte salts further expansion | 1,100 metric tonnes by Sep 2025, 1,000 metric tonnes by Mar 2026 |
| Electrolyte capacity commissioned at Dahej | 2,000 metric tonnes |
| Neogen Chemicals level total debt | ~₹400–500 cr including working capital of ~₹450 cr |
| Neogen Ionics level debt | ~₹1,100–1,200 cr, ~70% of ₹1,500 cr funded by bank |
| Standalone working capital cycle target | 140–150 days; long-term target 110–120 days |
| Neogen Ionics working capital target | Below 90 days; consolidated long-term target below 100 days |